Blackrock Health Sciences Trust Ii · net assets $2.02B · 390 holdings as of March 31, 2023. Monthly N-PORT disclosure: the full book, not just equities.
EC: 96.1% · STIV: 2.6% · EP: 2.2% · DFE: 0.0% · OTHER: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $0 | $0 | $0 |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $13.9M | $4.73M | $3.32M |
| Net realized gain (non-derivative) | $19.3M | $-12.9M | $-8.13M |
| Net unrealized appreciation (non-derivative) | $61.3M | $-74M | $48.3M |
The three months of the reporting period, as filed; month 3 ends March 31, 2023.
| Holding | Value | % of net assets |
|---|---|---|
| Vertex Pharmaceuticals Inc EC | $55.6M | 2.75% |
| Alcon Inc EC | $51.9M | 2.57% |
| Penumbra Inc EC | $48.8M | 2.41% |
| West Pharmaceutical Services Inc EC | $46.5M | 2.30% |
| Resmed Inc EC | $45.9M | 2.27% |
| Dexcom Inc EC | $42M | 2.08% |
| Insulet Corp EC | $37.2M | 1.84% |
| Cooper Cos Inc/the EC | $37M | 1.83% |
| Stryker Corp EC | $36.5M | 1.80% |
| Alnylam Pharmaceuticals Inc EC | $35.6M | 1.76% |
| Biomarin Pharmaceutical Inc EC | $35.5M | 1.75% |
| Mettler-toledo International Inc EC | $33M | 1.63% |
| Alkermes PLC EC | $32.8M | 1.62% |
| Intuitive Surgical Inc EC | $32.4M | 1.60% |
| Amerisourcebergen Corp EC | $31M | 1.53% |
| Hologic Inc EC | $30.8M | 1.52% |
| Ucb Sa EC | $30.8M | 1.52% |
| Regeneron Pharmaceuticals Inc EC | $30.5M | 1.51% |
| Steris PLC EC | $30.4M | 1.50% |
| Waters Corp EC | $30.2M | 1.49% |
| Qiagen Nv EC | $29.6M | 1.47% |
| Neurocrine Biosciences Inc EC | $27.2M | 1.34% |
| Blackrock Liquidity Funds STIV | $26.9M | 1.33% |
| Iqvia Holdings Inc EC | $25.3M | 1.25% |
| Gerresheimer Ag EC | $24.1M | 1.19% |
| Incyte Corp EC | $24M | 1.18% |
| Masimo Corp EC | $23.3M | 1.15% |
| Repligen Corp EC | $23.3M | 1.15% |
| Adicon Holdings Limited EP | $23.2M | 1.15% |
| Money Market Series A Series Of Sl Liquidity Series, LLC STIV | $22.9M | 1.13% |
| Catalent Inc EC | $22.8M | 1.13% |
| Boston Scientific Corp EC | $22.8M | 1.13% |
| Gilead Sciences Inc EC | $21.1M | 1.04% |
| Daiichi Sankyo Co Ltd EC | $20.5M | 1.01% |
| Carbon Health Technologies Inc EC | $20.1M | 0.99% |
| Align Technology Inc EC | $19.8M | 0.98% |
| Thermo Fisher Scientific Inc EC | $17.1M | 0.85% |
| Astrazeneca PLC EC | $17M | 0.84% |
| Zoetis Inc EC | $16.9M | 0.84% |
| Ionis Pharmaceuticals Inc EC | $16.7M | 0.83% |
| Straumann Holding Ag EC | $16.6M | 0.82% |
| Bruker Corp EC | $16.4M | 0.81% |
| Seagen Inc EC | $16M | 0.79% |
| Immunocore Limited EC | $15.9M | 0.79% |
| Sarepta Therapeutics Inc EC | $15.8M | 0.78% |
| Da32 Life Science Tech Acquisition Corp EC | $15.1M | 0.75% |
| Danaher Corp EC | $14.5M | 0.71% |
| Tandem Diabetes Care Inc EC | $14.1M | 0.69% |
| Avantor Inc EC | $14M | 0.69% |
| Psiquantum Corp EC | $13.7M | 0.68% |
| Genmab A/s EC | $13.2M | 0.65% |
| Novocure Ltd EC | $12.8M | 0.63% |
| Blueprint Medicines Corp EC | $12.7M | 0.63% |
| United Therapeutics Corp EC | $12.5M | 0.62% |
| Convatec Group PLC EC | $12.5M | 0.62% |
| Argenx Se EC | $12.3M | 0.61% |
| Rhythm Pharmaceuticals Inc EC | $12.2M | 0.60% |
| Laronde Inc Series B EC | $12.1M | 0.60% |
| Shockwave Medical Inc EC | $11.6M | 0.58% |
| Exelixis Inc EC | $11.6M | 0.58% |
Showing top 60 of 390 holdings.
Loading...
